JP2022523024A5 - - Google Patents

Info

Publication number
JP2022523024A5
JP2022523024A5 JP2021542206A JP2021542206A JP2022523024A5 JP 2022523024 A5 JP2022523024 A5 JP 2022523024A5 JP 2021542206 A JP2021542206 A JP 2021542206A JP 2021542206 A JP2021542206 A JP 2021542206A JP 2022523024 A5 JP2022523024 A5 JP 2022523024A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
seq
sequence
ile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021542206A
Other languages
English (en)
Japanese (ja)
Other versions
JP7672979B2 (ja
JP2022523024A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/014382 external-priority patent/WO2020154275A1/en
Publication of JP2022523024A publication Critical patent/JP2022523024A/ja
Publication of JP2022523024A5 publication Critical patent/JP2022523024A5/ja
Priority to JP2025071352A priority Critical patent/JP7887525B2/ja
Application granted granted Critical
Publication of JP7672979B2 publication Critical patent/JP7672979B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021542206A 2019-01-22 2020-01-21 G12r変異を有するrasに対するhlaクラスii拘束性t細胞受容体 Active JP7672979B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025071352A JP7887525B2 (ja) 2019-01-22 2025-04-23 G12r変異を有するrasに対するhlaクラスii拘束性t細胞受容体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962795203P 2019-01-22 2019-01-22
US62/795,203 2019-01-22
PCT/US2020/014382 WO2020154275A1 (en) 2019-01-22 2020-01-21 Hla class ii-restricted t cell receptors against ras with g12r mutation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025071352A Division JP7887525B2 (ja) 2019-01-22 2025-04-23 G12r変異を有するrasに対するhlaクラスii拘束性t細胞受容体

Publications (3)

Publication Number Publication Date
JP2022523024A JP2022523024A (ja) 2022-04-21
JP2022523024A5 true JP2022523024A5 (cg-RX-API-DMAC7.html) 2023-01-31
JP7672979B2 JP7672979B2 (ja) 2025-05-08

Family

ID=69591774

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021542206A Active JP7672979B2 (ja) 2019-01-22 2020-01-21 G12r変異を有するrasに対するhlaクラスii拘束性t細胞受容体
JP2025071352A Active JP7887525B2 (ja) 2019-01-22 2025-04-23 G12r変異を有するrasに対するhlaクラスii拘束性t細胞受容体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025071352A Active JP7887525B2 (ja) 2019-01-22 2025-04-23 G12r変異を有するrasに対するhlaクラスii拘束性t細胞受容体

Country Status (9)

Country Link
US (2) US12448428B2 (cg-RX-API-DMAC7.html)
EP (1) EP3914612A1 (cg-RX-API-DMAC7.html)
JP (2) JP7672979B2 (cg-RX-API-DMAC7.html)
KR (1) KR102934104B1 (cg-RX-API-DMAC7.html)
CN (2) CN113412277B (cg-RX-API-DMAC7.html)
AU (1) AU2020211922B2 (cg-RX-API-DMAC7.html)
CA (1) CA3127096A1 (cg-RX-API-DMAC7.html)
TW (1) TWI923548B (cg-RX-API-DMAC7.html)
WO (1) WO2020154275A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024507929A (ja) 2021-02-25 2024-02-21 アラウノス セラピューティクス インコーポレイテッド 多シストロン性発現カセットを含む組換えベクター及びそれらの使用方法
WO2023150562A1 (en) 2022-02-01 2023-08-10 Alaunos Therapeutics, Inc. Methods for activation and expansion of t cells
AU2024309123A1 (en) 2023-06-28 2026-01-15 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services T cell receptors targeting ras with g12d, g12r, or g12v mutation
CN119119290B (zh) * 2024-07-15 2025-11-25 上海交通大学医学院附属瑞金医院 靶向flt3 d835h突变衍生新抗原的tcr及应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8034334B2 (en) 2002-09-06 2011-10-11 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy
US8383099B2 (en) 2009-08-28 2013-02-26 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Adoptive cell therapy with young T cells
US20120244133A1 (en) 2011-03-22 2012-09-27 The United States of America, as represented by the Secretary, Department of Health and Methods of growing tumor infiltrating lymphocytes in gas-permeable containers
SI2755997T1 (sl) 2011-09-15 2018-11-30 The United States of America, as represented by Secretary, Department of Health and Human Services, Office of Technology Transfer, National Institutes of Health T-celični receptorji, ki prepoznajo HLA-A1- ali HLA-CW7-omejeni mage
WO2015123532A1 (en) 2014-02-16 2015-08-20 Globeimmune, Inc. Ras g12r immunotherapy for ras mutation-positive cancers
SG10201913978RA (en) * 2014-11-26 2020-03-30 The United States Of America As Represented By The Secretary Anti-mutated kras t cell receptors
JP2018518177A (ja) 2015-06-16 2018-07-12 タルゴバックス エーエスエー Rasタンパク質の突然変異フラグメント
SG10201913868XA (en) * 2015-09-15 2020-03-30 The United States Of America As Represented By The Secretary T cell receptors recognizing hla-cw8 restricted mutated kras
DE102016115246C5 (de) 2016-08-17 2018-12-20 Immatics Biotechnologies Gmbh Neue t-zellrezeptoren und deren verwendung in immuntherapie
CN108264550B (zh) 2017-01-04 2021-04-23 香雪生命科学技术(广东)有限公司 一种识别源自于prame抗原短肽的tcr
CN108395479B (zh) 2017-02-06 2021-07-16 高军 一种有关kras基因突变的t细胞受体
AU2024309123A1 (en) 2023-06-28 2026-01-15 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services T cell receptors targeting ras with g12d, g12r, or g12v mutation

Similar Documents

Publication Publication Date Title
US7807792B2 (en) Tumor antigen based on products of the tumor suppressor gene WT1
JP2020534828A5 (cg-RX-API-DMAC7.html)
JP2021505136A5 (cg-RX-API-DMAC7.html)
JP7832111B2 (ja) G12d突然変異rasに対するhlaクラスi拘束性t細胞受容体
JP7742354B2 (ja) G12v変異を有するrasに対するhlaクラスii拘束性t細胞受容体
WO2021211455A1 (en) Hla class i-restricted t cell receptors against lmp2
JP2023534241A5 (cg-RX-API-DMAC7.html)
JP2025114614A (ja) G12r変異を有するrasに対するhlaクラスii拘束性t細胞受容体
CN113621048A (zh) T细胞抗原受体、其多聚体复合物及其制备方法和应用
CN114302962A (zh) 特异性针对来源于ebv抗原的tcr构建体
AU2024309123A1 (en) T cell receptors targeting ras with g12d, g12r, or g12v mutation
JP2023534241A (ja) G12d変異を有するrasに対するhlaクラスii拘束性drb t細胞受容体
JP2023540123A5 (cg-RX-API-DMAC7.html)
JP2023535366A5 (cg-RX-API-DMAC7.html)
GB2614166A (en) T cell receptors recognizing R273C or Y220C mutations in P53
US8658177B2 (en) Promiscuous HER-2/Neu CD4 T cell epitopes
JP2023535366A (ja) G12v変異を有するrasに対するhlaクラスii拘束性drb t細胞受容体
NZ805541A (en) Hla class i-restricted t cell receptors against mutated ras